Sustainability vs. Sterility: Can Single-Use Technologies Become Greener?
July 28, 2026
Single-use technologies (SUTs) have transformed biopharmaceutical manufacturing over the past two decades. Disposable bioreactors, tubing, filters, and bags have enabled faster facility start-ups, reduced cleaning validation requirements, and increased manufacturing flexibility—particularly for biologics and advanced therapies.
Yet as sustainability becomes a strategic priority across the life sciences industry, manufacturers are facing a new challenge: How can they balance operational efficiency with environmental responsibility?
The Sustainability Dilemma
Single-use systems significantly reduce water consumption, energy use, and chemical cleaning compared to traditional stainless-steel facilities. They eliminate lengthy cleaning cycles, reduce cross-contamination risks, and accelerate product changeovers.
However, these advantages come with a trade-off.
The growing volume of disposable plastic waste has become one of the industry's biggest sustainability concerns. Components often consist of multiple polymer layers that are difficult to recycle and are commonly disposed of through incineration.
As environmental regulations tighten and companies strengthen their ESG commitments, reducing the environmental footprint of single-use manufacturing has become an industry priority.
Innovation Beyond Waste Reduction
Manufacturers and suppliers are increasingly exploring ways to make single-use technologies more sustainable without compromising product quality or patient safety.
Current initiatives include:
- Designing components with recyclable materials
- Developing take-back and recycling programs
- Reducing packaging waste
- Optimizing supply chains to lower transportation emissions
- Improving lifecycle assessments for manufacturing equipment
Rather than replacing single-use technologies altogether, many organizations are focusing on improving their entire lifecycle—from manufacturing to disposal.
Sustainability Requires Collaboration
Engineering teams, procurement specialists, suppliers, and sustainability leaders all play an important role in reducing environmental impact.
Facility design decisions, supplier selection, waste management strategies, and process optimization all contribute to a more sustainable manufacturing operation.
As the industry continues to grow, sustainability will no longer be measured solely by carbon emissions but by how intelligently manufacturing systems are designed throughout their lifecycle.
Looking Ahead
The future of pharmaceutical manufacturing is not about choosing between sterility and sustainability—it is about achieving both.
Innovation in materials, circular economy initiatives, and smarter facility design will allow manufacturers to continue benefiting from single-use technologies while reducing their environmental impact.
Sustainability is becoming another measure of manufacturing excellence, and companies that invest in greener solutions today will be better positioned for tomorrow's regulatory and market expectations.
Related
The Future of Sterile Fill-Finish: How Advanced Manufacturing Is Redefining Injectable Production
The future of sterile fill-finish is becoming faster, smarter and more automated. Jubilant Pharmova’s latest FDA-cleared isolator-based manufacturing line in Spokane highlights how advanced technology is helping the industry expand injectable production while strengthening sterility assurance, flexibility and quality.
Roche and Eli Lilly Advance Alzheimer’s Diagnosis With FDA-Cleared pTau217 Blood Test
A simple blood test could change how Alzheimer’s disease is detected and assessed. Roche and Eli Lilly’s newly FDA-cleared pTau217 test brings blood-based biomarker testing one step closer to routine clinical care, potentially making Alzheimer’s assessment more accessible, scalable and less invasive.
